CRISPR–Cas9-based therapies are widely investigated for their clinical applications. However, there are limitations ...

Key market opportunities in the global competent cells market include rising demands in genetic engineering and synthetic ...

Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and ...

Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and ...

SHERLOCK, a rapid CRISPR-based diagnostic, detects Candida auris and antifungal resistance mutations in patient samples in under an hour.

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...

Scientists from UC Davis Center for Surgical Bioengineering, the MIND Institute and UC Berkeley’s Murthy Lab are developing ...

Nick Edwards, PhD, CEO of Potato, has a “burning desire” to speed up scientific discovery. In an interview with GEN, he explained how Potato’s AI “scientist,” named Tater, recently replicated a main ...

Synthego, a recognized leader in CRISPR solutions, announces its formal entry into the molecular and clinical diagnostic reagents sector. Building upon its reputation for rigorous quality, custom ...

To combat this problem, scientists have been attempting to use genetic engineering to help crops control their own ...

Vojislav Gligorovski is one of only six recipients of the global International Birnstiel Award for Doctoral Research in ...